Development and validation of a clinical prediction model for postcontrast acute kidney injury in patients with postoperative acute kidney injury of acute Stanford type A aortic dissection - Summary - MDSpire

Development and validation of a clinical prediction model for postcontrast acute kidney injury in patients with postoperative acute kidney injury of acute Stanford type A aortic dissection

  • By

  • Weiwei Zhao

  • Min Ge

  • YongQing Cheng

  • Ming Chen

  • Qing Zhou

  • Wenkui Yu

  • July 10, 2026

  • 0 min

Share

Objective:

To identify independent risk factors for postcontrast acute kidney injury (PC-AKI) in patients with postoperative AKI (PO-AKI) following acute Stanford type A aortic dissection (ATAAD), and to develop a prediction model for clinical use.

Approach:
  • Study Design: This retrospective cohort study enrolled 604 PO-AKI patients from January 2014 to December 2024 at Nanjing Drum Tower Hospital who underwent postoperative contrast-enhanced CTA.
  • Model Development: Three variable-selection strategies (backward stepwise AIC, LASSO, and XGBoost-SHAP) were used; a multivariable logistic regression model was constructed and validated through bootstrap resampling.
Key Findings:
  • PC-AKI incidence was 9.8% (59/604), with significant recovery-dependent stratification: 3.5% in fully recovered PO-AKI vs. 52.5% in unrecovered PO-AKI.
  • Independent predictors included PO-AKI stage 3 (OR = 3.144, 95% CI: 1.41–7.06) and unrecovered PO-AKI before first CTA (OR = 25.212, 95% CI: 12.57–53.49).
  • The model exhibited good discrimination (AUC=0.848, 95% CI: 0.78–0.91) and calibration (Brier=0.057).
  • PC-AKI was associated with prolonged ICU stay (RR = 1.521, 95% CI: 1.19–1.97) and incomplete renal recovery at discharge (OR = 2.554, 95% CI: 1.30–4.86).
Interpretation:

Dynamic PO-AKI recovery and advanced AKI stage are associated with PC-AKI risk in post-ATAAD patients.

Limitations:
  • External validation of the prediction model is needed before clinical deployment to ensure its applicability in broader settings.
Conclusion:

The internally validated model may aid individualized risk stratification before contrast procedures in this high-risk subgroup.

Original Source(s)

Related Content